T. Rowe Price Group

T. Rowe Price Group, Inc. is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company offers a diverse range of services, including separate account management, mutual funds, and sub-advisory services, catering to individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price manages investments in both public equity and fixed income markets globally, employing a combination of fundamental and quantitative analysis with a bottom-up investment approach. The firm also engages in socially responsible investing, focusing on environmental, social, and governance issues. In addition to traditional investment strategies, T. Rowe Price participates in late-stage venture capital investments, typically investing between $3 million and $5 million. The company operates numerous offices worldwide, reinforcing its commitment to delivering investment excellence over the long term.

Ziad Bakri

Vice President

Oliver Bell

Associate Head of International Equities, Portfolio Manager, Member of the International Equity Steering Committee and Board Member of T. Rowe Price (Luxembourg) Management

Eiswert C.F.A., CFA, David J.

Vice President and Portfolio Manager

Jennifer St. Germain

Vice President

John Hall

Investment Analyst

Kenneth Moreland

CFO and Treasurer

Julio Novo

Investor

Anthony Wang

Portfolio Manager - Vice President T. Rowe Price Group

Jeff Zoller

Vice President

Past deals in CAD

Canva

Venture Round in 2021
Canva, Inc. is a graphic design software provider that offers an online platform enabling users to create presentations, social media graphics, and other visual content. The platform features a user-friendly drag-and-drop design tool, along with a vast library of layouts, images, photo filters, icons, shapes, and fonts. Canva's products include web-based applications and an iPad version, as well as a plug-in called Canva Button that allows third-party websites to integrate design capabilities for their users. Founded in 2012 and headquartered in Sydney, Australia, Canva serves a global audience including photographers, illustrators, and designers, and also provides support services to enhance user experience.

CCC Drive

Post in 2021
CCC Drive, based in Glen Allen, Virginia, provides a versatile technology platform for insurance telematics, known as DriveFactor. This platform allows for the integration of data from various sources and facilitates sharing with business partners. CCC Drive enables clients to manage the entire claims process, including intake, evaluation, settlement, and optimization. The company, originally founded in 2010 as DriveFactor Inc., became a subsidiary of CCC Information Services Inc. in 2015. CCC Information Services focuses on enhancing claims management through integrated solutions, offering advanced collision repair and insurance estimating software, analytical tools, and data services. Their technology improves efficiency across the claims management supply chain, fostering communication among a network of approximately 21,000 auto body collision repair facilities and 350 insurance companies.

Canva

Venture Round in 2021
Canva, Inc. is a graphic design software provider that offers an online platform enabling users to create presentations, social media graphics, and other visual content. The platform features a user-friendly drag-and-drop design tool, along with a vast library of layouts, images, photo filters, icons, shapes, and fonts. Canva's products include web-based applications and an iPad version, as well as a plug-in called Canva Button that allows third-party websites to integrate design capabilities for their users. Founded in 2012 and headquartered in Sydney, Australia, Canva serves a global audience including photographers, illustrators, and designers, and also provides support services to enhance user experience.

Kardium

Private Equity Round in 2021
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.

Kardium

Private Equity Round in 2019
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.

Advanced Accelerator Applications

Venture Round in 2015
Advanced Accelerator Applications (AAA), is a European Pharmaceutical Group founded in 2002 by Italian academics as a spin-off of the “European Organization for Nuclear Research” (CERN), Geneva, Switzerland), to develop innovative diagnostic and therapeutic products. AAA’s main focus is in the field of Molecular Imaging and targeted, individualized therapy for the management of patients with serious conditions (Personalized Medicine). AAA is a European leader in the production and commercialization of PET (Positron Emission Tomography) radiopharmaceuticals. PET is a state-of-the-art diagnostic technique that is today mainly used in clinical oncology, cardiology and neurology. AAA also produces a broad range of SPECT products. AAA currently has 17 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 300 employees in 11 countries (France, Italy, UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, United States and Canada).
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

OANDA

Series B in 2007
OANDA Corporation is a global provider of internet-based foreign exchange (forex) trading and currency information services, catering to individuals, corporations, portfolio managers, and financial institutions. Founded in 1995 and headquartered in Toronto, the company offers several platforms, including fxTrade, which features advanced charting tools and market analysis, and a mobile version for iOS and Android devices. Additionally, OANDA provides the MetaTrader 4 platform, known for its automated trading capabilities, and various APIs for automated trading across a range of financial instruments. The company also delivers currency information, analytics, and educational resources, making it a valuable resource for traders and investors alike. With offices in major cities worldwide, OANDA combines technology and financial expertise to facilitate forex trading and provide comprehensive market insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.